BioCryst Pharmaceuticals, Inc.
BCRX
$8.80
$0.222.56%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.21% | -14.37% | -35.50% | -4.41% | -12.32% |
| Total Receivables | 17.00% | 35.09% | 26.04% | 32.60% | 54.15% |
| Inventory | -12.92% | -33.25% | -30.81% | 13.35% | -76.92% |
| Prepaid Expenses | 33.41% | 24.94% | 1.36% | -23.65% | -22.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 193.47% | -4.29% | 3,559.53% | 1,552.48% | -83.82% |
| Total Current Assets | -8.87% | -4.18% | -16.73% | 9.63% | -8.30% |
|
|
|||||
| Total Current Assets | -8.87% | -4.18% | -16.73% | 9.63% | -8.30% |
| Net Property, Plant & Equipment | 17.42% | -4.04% | -2.01% | 0.77% | -5.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 59.86% | 4.65% | 26.97% | 15.44% | 37,807.59% |
| Total Assets | -3.12% | 4.84% | -9.13% | -3.22% | 2.60% |
|
|
|||||
| Total Accounts Payable | 9.05% | 35.92% | -58.71% | 10.31% | -15.63% |
| Total Accrued Expenses | 28.89% | 11.58% | 13.99% | 19.55% | 16.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.78% | 13.08% | 9.98% | 19.15% | 29.24% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 39.71% | 22.25% | 23.88% | 37.26% | 16.62% |
|
|
|||||
| Total Current Liabilities | 39.71% | 22.25% | 23.88% | 37.26% | 16.62% |
| Long-Term Debt | 2.60% | -46.32% | -20.43% | -14.58% | -3.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.82% | -0.36% | 0.25% | 0.51% | -9.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.33% | -34.46% | -13.08% | -7.30% | -1.28% |
|
|
|||||
| Common Stock & APIC | 27.15% | 7.25% | 7.12% | 7.07% | 6.24% |
| Retained Earnings | -25.87% | 14.91% | -0.50% | -2.07% | -3.11% |
| Treasury Stock & Other | -132.51% | -95.87% | -50.28% | 195.51% | 46.82% |
| Total Common Equity | -22.55% | 74.96% | 17.22% | 11.36% | 5.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.55% | 74.96% | 17.22% | 11.36% | 5.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.55% | 74.96% | 17.22% | 11.36% | 5.09% |
|
|
|||||